Publicaciones en colaboración con investigadores/as de Universitat de Barcelona (53)

2024

  1. Additional file 2 of Staphylococcus aureus surgical site infection rates in 5 European countries

    figshare

  2. Additional file 2 of Staphylococcus aureus surgical site infection rates in 5 European countries

    figshare

  3. Corrigendum to “Safety and effectiveness of isavuconazole in real-life non-neu tropenic patients” [International Journal of Infectious Diseases 144 (2024) 107070] (International Journal of Infectious Diseases (2024) 144, (S1201971224001413), (10.1016/j.ijid.2024.107070))

    International Journal of Infectious Diseases

  4. Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK

    Journal of Hospital Infection, Vol. 147, pp. 123-132

  5. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials

    The Lancet Infectious Diseases, Vol. 24, Núm. 3, pp. 319-328

  6. Individual and institutional predisposing factors of MRSA surgical site infection and outcomes-a retrospective case-control-study in 14 European high-volume surgical centres

    JAC-Antimicrobial Resistance, Vol. 6, Núm. 2

  7. Isavuconazole Versus Voriconazole as the First-line Therapy for Solid Organ Transplant Recipients With Invasive Aspergillosis: Comparative Analysis of 2 Multicenter Cohort Studies

    Transplantation, Vol. 108, Núm. 11, pp. 2260-2269

  8. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

  9. Safety and effectiveness of isavuconazole in real-life non-neutropenic patients

    International Journal of Infectious Diseases, Vol. 144